Information: This is an outdated version of the data model. You can find a Versions overview via Versions on the left. You can find the newest Version by clicking here.
Information:
Error:
ID
13643
Description
Intellectual Impairment in Women With Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00896324
Link
https://clinicaltrials.gov/show/NCT00896324
Keywords
Versions (2)
- 2/22/16 2/22/16 -
- 9/20/21 9/20/21 -
Uploaded on
February 22, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer NCT00896324
Eligibility Breast Cancer NCT00896324
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00896324
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Malignant neoplasm of breast Primary Non-Metastatic Neoplasm
Item
3.1.1 primary, non-metastatic breast cancer
boolean
C0006142 (UMLS CUI [1,1])
C0205225 (UMLS CUI [1,2])
C1334991 (UMLS CUI [1,3])
C0205225 (UMLS CUI [1,2])
C1334991 (UMLS CUI [1,3])
newly diagnosed breast cancer
Item
3.1.2 newly diagnosed patients who have not yet begun treatment.
boolean
C1518321 (UMLS CUI [1,1])
C0006142 (UMLS CUI [1,2])
C0006142 (UMLS CUI [1,2])
age; female; english speaking
Item
3.1.4 female participants age 40-65 years of all ethnicities who speak fluent english will be recruited.
boolean
C0001779 (UMLS CUI [1])
C0015780 (UMLS CUI [2])
C0376245 (UMLS CUI [3])
C0015780 (UMLS CUI [2])
C0376245 (UMLS CUI [3])
life expectancy
Item
3.1.5 there are no life expectancy restrictions.
boolean
C0023671 (UMLS CUI [1])
karnofsky performance status; ECOG
Item
3.1.6 karnofsky performance status 70% minimum. ecog will not be employed.
boolean
C0206065 (UMLS CUI [1])
C1520224 (UMLS CUI [2])
C1520224 (UMLS CUI [2])
function bone marrow; neuropathology
Item
3.1.7 there are no requirements for marrow function. the brain must be free from gross neuropathology and metastases in order to participate.
boolean
C1254358 (UMLS CUI [1,1])
C0005953 (UMLS CUI [1,2])
C0876934 (UMLS CUI [2])
C0005953 (UMLS CUI [1,2])
C0876934 (UMLS CUI [2])
informed consent
Item
3.1.8 ability to understand and the willingness to sign a written informed consent document.
boolean
C0021430 (UMLS CUI [1])
Compliance behavior Limited Comorbidity
Item
3.2.1 history of cognitive, psychiatric or medical conditions prior or unrelated to cancer diagnosis and/or known to significantly impact assessments (e.g. premature birth, developmental delays, learning disabilities, severe psychiatric conditions, brain injury, stroke). non-english speaking. major sensory impairment (e.g. hearing loss, blindness) that would render assessments invalid. mri contraindications (e.g. metallic implants or devices). distant metastases. see also section 4.2.1.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
Study Subject Participation Status
Item
3.2.2 participants currently involved in studies specifically aimed at improving cognitive symptoms will be excluded.
boolean
C2348568 (UMLS CUI [1])
comorbidity
Item
3.2.3 participants with significant co-morbid diseases known to significant impact neuropsychological function such as alzheimer's or parkinson's will be excluded.
boolean
C0009488 (UMLS CUI [1,1])
C0205494 (UMLS CUI [1,2])
C0205494 (UMLS CUI [1,2])
hypersensitivity
Item
3.2.4 there are no known risks for allergic reactions to any of the study procedures.
boolean
C0020517 (UMLS CUI [1])
concomitant medication; ritalin; anti-depressants
Item
3.2.5 participants taking certain medications that affect neuropsychological and/or brain function including haldol, aricept, ritalin, etc. will be excluded. most anti-depressants are acceptable. some anti-anxiety medications may not be. each case will be individually reviewed.
boolean
C2347852 (UMLS CUI [1])
C0728759 (UMLS CUI [2])
C0003290 (UMLS CUI [3])
C0728759 (UMLS CUI [2])
C0003290 (UMLS CUI [3])
exclusion criteria
Item
3.2.6 there are no other agent-specific exclusion criteria.
boolean
C0680251 (UMLS CUI [1])
pregnant
Item
3.2.7 pregnant individuals will be excluded as this is a contraindication for the 3 tesla research mri scanner employed by this study but not because of the treatment programs per se. nursing individuals can enroll.
boolean
C0032961 (UMLS CUI [1])
hiv positive; cognitive function
Item
3.2.8 patients who are hiv positive will be excluded given the known effects of this condition on cognitive function which would confound the effects of anti-cancer treatments on cognitive outcome.
boolean
C0019699 (UMLS CUI [1])
C0392335 (UMLS CUI [2])
C0392335 (UMLS CUI [2])